5 of Last Week's Biggest Winners

What's better than momentum? Mo' momentum. Let's take a closer look at five of this past week's biggest scorchers.

Company

Dec. 6

Weekly Gain

Plug Power (NASDAQ: PLUG  )

$2.06

178%

XOMA (NASDAQ: XOMA  )

$6.02

26%

Gogo (NASDAQ: GOGO  )

$32.89

23%

Cheniere Energy (NYSEMKT: LNG  )

$44.90

13%

Marketo (NASDAQ: MKTO  )

$32.38

11%

Source: Barron's.

Let's start with Plug Power. The fuel-cell maker was the market's biggest winner, nearly tripling on the week after announcing that it will be profitable next year. Plug Power has been having a strong fourth quarter, and it now sees between $30 million and $40 million in orders for the current quarter. When you factor in its forecast for shipments in 2014 and the recurring revenue from product, service, and hydrogen contracts, this historically profitless company is in good shape to be in the black next year.

XOMA moved higher after its CEO had an encouraging presentation at a Piper Jaffray health-care conference on Wednesday afternoon. He updated the attendees on the biotech's pipeline, providing some color on the potential of XOMA's promising treatments.

Gogo was another winner, after the in-flight Wi-Fi provider received certification to install its online connectivity platform in Boeing 747-400 aircraft. This is an important milestone, since getting its Ku-satellite technology in Boeing 747-400 planes is a way to take its growing domestic reach global.

Cheniere Energy signed its first deal to deliver liquefied natural gas from its Corpus Christi project. Pertamina will be buying roughly 0.8 million tonnes of liquefied natural gas a year. Cheniere also revealed plans to take a fully owned subsidiary public.

Finally, we have Marketo on the move. The cloud-based marketing software provider had its CEO speak at the 2013 Credit Suisse Technology Conference, helping expand the awareness of the recent IPO's business and prospects. It also kicked off the week by announcing a deal with biotech IT services provider HighPoint Solutions.

Keep the winners coming with these two game-changers
The best way to play the biotech space is to find companies that shun the status quo and instead discover revolutionary, groundbreaking technologies. In The Motley Fool's brand-new free report "2 Game-Changing Biotechs Revolutionizing the Way We Treat Cancer," find out about a new technology that big pharma is endorsing through partnerships, and the two companies that are set to profit from this emerging drug class. Click here to get your copy today.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2756622, ~/Articles/ArticleHandler.aspx, 10/20/2014 1:11:40 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement